Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells

Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells

Ruthenium atoms located in the surfaces of carbosilane dendrimers markedly increase their anti-tumor properties. Carbosilane dendrimers have been widely studied as carriers of drugs and genes owing to such characteristic features as monodispersity, stability, and multivalence. The presence of ruthen...

Full description

Bibliographic Details
Main Authors: Sylwia Michlewska, Maksim Ionov, Aleksandra Szwed, Aneta Rogalska, Natalia Sanz del Olmo, Paula Ortega, Marta Denel, Damian Jacenik, Dzmitry Shcharbin, Francisco Javier de la Mata, Maria Bryszewska
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:International Journal of Molecular Sciences
Subjects:
1301 human lymphoblastic leukemia
carbosilane dendrimer
ruthenium
drug delivery
cytotoxicity
Online Access:https://www.mdpi.com/1422-0067/21/11/4119

Internet

https://www.mdpi.com/1422-0067/21/11/4119

Similar Items